Junevity is a biotech company pioneering siRNA for transcription factors to reset cell health. The proprietary RESET Platform is the first to use human genomic data, AI/ML, and siRNA to unlock transcription factor targets. The company's lead programs are in Diabetes and Obesity, with preclinical programs in CNS, Osteoarthritis and Sarcopenia. Based on nearly a decade of foundational research, Junevity’s mission is to extend human lifespan and healthspan.
Company Details
- Employees
- 13
- Founded
- -
- Address
- San Francisco, Ca 94107, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://junevity.com
- Keywords
- Biotechnology, Age-related disease, Bioinformatics, Therapeutics, Genomics, Drug Discovery, AI, Machine Learning, Longevity, siRNA.
- HQ
- San Francisco, CA
Junevity Questions
Junevity's website is http://junevity.com
Junevity's LinkedIn profile is https://www.linkedin.com/company/junevity
Junevity has
13 employees.
View email and phone details for 13
employees at Junevity.
Junevity's industry is
Biotechnology Research
Junevity's top competitors are
Retro Biosciences,
Latent Labs,
Impel Pharmaceuticals,
Level Zero Health,
Insidetracker,
Shift Bioscience,
Clock.bio,
Fauna Bio,
Abalone Bio,
Radar Therapeutics.
Junevity's categories are Biotechnology Research
Junevity's founding year is 2023
